Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
GPR149 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 149 Similarity and Patent-Risk Signals
8 min read
GPR149 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 149 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR149 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GPR153 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 153 Similarity and Patent-Risk Signals
8 min read
GPR153 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 153 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR153 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
CXCL11 Biologics Sequence Review Report 2026: C-X-C motif chemokine 11 Similarity and Patent-Risk Signals
8 min read
CXCL11 Biologics Sequence Review Report 2026: C-X-C motif chemokine 11 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CXCL11 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
CDHR3 Biologics Sequence Review Report 2026: Cadherin-related family member 3 Similarity and Patent-Risk Signals
8 min read
CDHR3 Biologics Sequence Review Report 2026: Cadherin-related family member 3 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CDHR3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
CDHR4 Biologics Sequence Review Report 2026: Cadherin-related family member 4 Similarity and Patent-Risk Signals
8 min read
CDHR4 Biologics Sequence Review Report 2026: Cadherin-related family member 4 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CDHR4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
CXCL10 Biologics Sequence Review Report 2026: C-X-C motif chemokine 10 Similarity and Patent-Risk Signals
8 min read
CXCL10 Biologics Sequence Review Report 2026: C-X-C motif chemokine 10 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CXCL10 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
CDHR5 Biologics Sequence Review Report 2026: Cadherin-related family member 5 Similarity and Patent-Risk Signals
8 min read
CDHR5 Biologics Sequence Review Report 2026: Cadherin-related family member 5 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CDHR5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
CDH8 Biologics Sequence Review Report 2026: Cadherin-8 Similarity and Patent-Risk Signals
8 min read
CDH8 Biologics Sequence Review Report 2026: Cadherin-8 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CDH8 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
CDH9 Biologics Sequence Review Report 2026: Cadherin-9 Similarity and Patent-Risk Signals
8 min read
CDH9 Biologics Sequence Review Report 2026: Cadherin-9 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CDH9 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
CDHR1 Biologics Sequence Review Report 2026: Cadherin-related family member 1 Similarity and Patent-Risk Signals
8 min read
CDHR1 Biologics Sequence Review Report 2026: Cadherin-related family member 1 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CDHR1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
CDH7 Biologics Sequence Review Report 2026: Cadherin-7 Similarity and Patent-Risk Signals
8 min read
CDH7 Biologics Sequence Review Report 2026: Cadherin-7 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CDH7 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
CDH6 Biologics Sequence Review Report 2026: Cadherin-6 Similarity and Patent-Risk Signals
8 min read
CDH6 Biologics Sequence Review Report 2026: Cadherin-6 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CDH6 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →